HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium Iodide → 1-[(E)-3-(3-Chloro-phenyl)-acryloyl]-4-(2-morpholin-4-yl-ethyl)-[1,4]diazepan-5-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | 4-(2-Chloro-ethyl)-1-[(E)-3-(3-chloro-phenyl)-acryloyl]-[1,4]diazepan-5-one | HCID 68432316 | — |
| Solvent | Dimethylacetamide | HCID 31374 | — |
| Product | 1-[(E)-3-(3-Chloro-phenyl)-acryloyl]-4-(2-morpholin-4-yl-ethyl)-[1,4]diazepan-5-one | HCID 68434255 | 8.2% |
Reaction Steps
A solution of 0.085 g (0.25 mmol) of 4-(2-chloro-ethyl)-1-[(E)-3-(3-chloro-phenyl)-acryloyl]-[1,4]diazepan-5-one in 1.3 ml of DMA was treated with 0.04 ml (0.50 mmol) of morpholine and stirred for 8 h at RT, a crystal of NaI was added and stirring was continued for 40 h. The reaction was extracted with aqueous saturated NaHCO3/EtOAc (3×). The organic phases were washed with aqueous 10% NaCl, dried (Na2SO4), concentrated and evaporated. Purification by catridges, Si-Amine, 70 ml, 20 g (EtOAc) gave 0.008 g (8%) of the title compound as off-white viscous oil. MS: 392.0 (MH+, Cl).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07632829B2 |
| Source dataset | uspto-grants-2009_12 |
| ORD ID | ord-dc1f02649b454e338c77715b26337b5a |
| Source note | uspto-grants-2009_12 |